Duke logo

Niclosamide for Colon Cancer - Clinical Trial

What is the Purpose of this Study?

We are doing this study to find out what effects (good and bad) that the study drug, niclosamide, has on you and your cancer.

We are trying to learn if giving niclosamide to people with cancer is safe and if it affects your cancer.

What is the Condition Being Studied?

Colon Cancer

Who Can Participate in the Study?

Adults who:
- Have color cancer
- Have brain metastases
- Not have an active infection including HIV or hepatitis

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- Be taking the study drug,niclosamide, by mouth every day for 7 days before your surgery.
- The dose of study drug and how often (either once per day or twice per day) you take it will depend on when you start the study.

Study Details

Full Title
A Phase I Study of Niclosamide in Patients with Resectable Colon Cancer
Principal Investigator
Protocol Number
IRB:PRO00066964
NCT:NCT02687009
Phase
Phase I
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
studyrecruitment@duke.edu
or
919-681-5698